Randomized Phase III Trial of Ganitumab with Interval-Compressed Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma: A Report from the Children's Oncology Group

  • Steven G. DuBois
  • , Mark D. Krailo
  • , Julia Glade-Bender
  • , Allen Buxton
  • , Nadia Laack
  • , R. Lor Randall
  • , Helen X. Chen
  • , Nita L. Seibel
  • , Matthew Boron
  • , Stephanie Terezakis
  • , Christine Hill-Kayser
  • , Andrea Hayes
  • , Joel M. Reid
  • , Lisa Teot
  • , Dinesh Rakheja
  • , Richard Womer
  • , Carola Arndt
  • , Stephen L. Lessnick
  • , Brian D. Crompton
  • , E. Anders Kolb
    • Heike Daldrup-Link, Eric Eutsler, Damon R. Reed, Katherine A. Janeway, Richard G. Gorlick

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Phase III Trial of Ganitumab with Interval-Compressed Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma: A Report from the Children's Oncology Group'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry